We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
LifebankUSA’s Breakthrough PlacentaCord™ Service Garners Attention
News

LifebankUSA’s Breakthrough PlacentaCord™ Service Garners Attention

LifebankUSA’s Breakthrough PlacentaCord™ Service Garners Attention
News

LifebankUSA’s Breakthrough PlacentaCord™ Service Garners Attention

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "LifebankUSA’s Breakthrough PlacentaCord™ Service Garners Attention"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

LifebankUSA, PlacentaCord banking, launched in October 2006, is the first service that banks stem cells from two sources – both the placenta and the umbilical cord.

PlacentaCord banking yields the most cells, which provides greater therapeutic potential for banking families.

Notably, LifebankUSA’s new PlacentaCord service was featured in an article written in the Newark Star-Ledger on January 7, entitled "Harvesting Hope." The article explored the growing interest in placental and cord blood banking through the experience of the Bogert family.

According to the article, parents-to-be Greg and Didi Bogert enrolled with LifebankUSA prior to the birth of their daughter, Brianna. After the birth of the baby girl, the Bogerts’ doctor performed the placenta and cord blood collection. Shortly after, a LifebankUSA courier arrived to transport the collection kit from the hospital to LifebankUSA’s facility for processing and cryogenic storage of the stem cells.

The Bogerts tell the Newark Star-Ledger that they are satisfied with their decision to invest in PlacentaCord banking.

"We're not really expecting something to happen so that we would need to resort to using the stem cells, but you never know," said Greg. "Who knows how far science will have advanced by the time our child is older? There may be cures we couldn't dream of today. To us, it's worth taking the chance."

Advertisement